Physician profile
Ami A Bhatt
NPI 1124373212
$1,557.74
in general payments reported to CMS, 2019-2025
20 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $18.89 · 2021: $115 · 2022: $246 · 2023: $304 · 2024: $203 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $329.40 | 2019-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $227.20 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $192.89 | 2019-2024 | Mounjaro, Zepbound |
| Phathom Pharmaceuticals, INC. | $178.35 | 2025 | Voquezna |
| Eli Lilly and Company | $148.07 | 2019 | |
| Exact Sciences Corporation | $83.62 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $74.84 | 2021-2025 | |
| Glaxosmithkline, LLC. | $55.73 | 2022-2023 | Shingrix, Arexvy |
| Abbott Laboratories | $41.60 | 2019-2022 | |
| Boston Scientific Corporation | $33.77 | 2025 | Watchman Flx |
| Ibsa Pharma INC. | $33.11 | 2021-2022 | |
| Astellas Pharma US INC | $26.73 | 2019 | |
| Shield Therapeutics INC | $26.52 | 2024 | |
| Novartis Pharmaceuticals Corporation | $26.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $16.90 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.70 | 2022 | |
| Amgen INC. | $13.12 | 2019 | |
| Eisai INC. | $12.36 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.10 | 2022 | |
| Phadia US INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.